Skip to main content

Table 2 Demographic and disease cCharacteristics for PsO patients

From: Differences in oxylipin profile in psoriasis versus psoriatic arthritis

Variable Psoriasis group N = 20
Age (years) (mean, SD) 51.9 (± 10.8)
Sex F:M 9:11 (55% male)
BMI (kg/m2) (mean, SD) 33.7 (± 6.8)
PASI (mean, SD) 3.8 (± 4.2)
BSA (mean, SD) 4.5 (± 4.7)
TJC 3.05 (4.8)
Enthesitis (%) 25%
Enthesitis (LEI mean) 1.5 (2.79)
NSAIDs (%) 35%
DMARDs 10%
TNF alpha inhibitors (%) 0
Corticosteroids (%) 0
Topical corticosteroids (%) 75%
  1. BMI body mass index, PASI Psoriasis Area and Severity Index, BSA body surface area, NSAID non-steroid anti-inflammatory drugs, DMARDs disease-modifying anti-rheumatic drugs, TNF tumor necrosis factor